Moreover, there are reports that a MUC-1-based anti-cancer vaccine was effective against breast, colon and lung cancers: a vaccine made using MUC-1 as antigen elicited adaptive host immunity (B or T cell response) targeting MUC-1-expressing cancer cells, and led to cancer cell death [66–68]. Here, MUC1 is linked to lung cancer.